首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 171 毫秒
1.
抗真菌蛋白Rs—AFPs基因在大肠杆菌中的表达   总被引:3,自引:0,他引:3  
将抗真菌蛋白Rs-AFP1和Rs-AFP2全长cDNA插入表达质粒pET-22b/NcoI+SacI位点,构建成融合蛋白表达载体pRAF1和pRAF2.将不含信号肽编码序列的Rs-AFP1和Rs-AFP2cDNA分别插入pET-22b/Ncol+Sacl和pET-22b/Ndel+SacI位点,构建成不含信号肽序列的融合蛋白表达载体pRAF3、pRAF4和非融合蛋白表达载体pRAF5和pRAF6.将构建的上述各种表达载体转化E.coliBL21,挑菌落培养,IPTG诱导,使Rs-AFPs基因得到表达,并用体外抑菌试验检测表达产物的活性,结果表明,各种表达载体的表达产物均具有不同程度的抑菌活性,其中,pRAF3和pRAF4表达产物的抑菌活性较明显.  相似文献   

2.
采用PCR定点突变方法,成功地构建了抗HBsAgdsFv抗体的轻、重链突变基因,NdeI和EcoRI酶切后分别插入pET20b表达质粒,经测序证明在重链第44位氨基酸和轻链第100位氨基酸已突变形成半胱氨酸(Cys)。VH和VL重组质粒分别转化到大肠肝菌BL21(DE3)中,IPTG诱导后,经SDSPAGE电泳表明在12kD处有包含体蛋白表达,表达蛋白含量分别为28%和35%。VH和VL包含体蛋白经GuHCl变性后,等量混合在复性折叠液中结合,形成了一个约24kD并有一定活性的dsFv蛋白。抗HBsAgdsFv抗体表达及复性的成功,为今后基因工程抗体的研究及应用奠定了基础。  相似文献   

3.
将抗癌胚抗原单链抗体基因与核心链霉亲和素基因融合插入昆虫杆状病毒供体质粒pFastBacHTa中,在粉纹夜蛾Tn-5B1-4细胞中进行表达。SDS-PAGE分析结果表明,表达产物分子量为41kD左右,Western印迹分析结果表明,以HRP标记的生物素进行蛋白质印迹在41kD处可见表达条带,表明融合蛋白能特异性的与生物素结合,放射免疫分析表明重组杆状病毒表达产生的ScFv-CS蛋白能特异性结合癌胚  相似文献   

4.
乙肝表面抗原专一的单链嵌合抗体在大肠杆菌中的表达   总被引:3,自引:0,他引:3  
潘华  杨冠珍 《遗传学报》1999,26(1):87-91
利用重组PCR技术将乙肝表面抗原专一单抗的Vk与人源的C基因拼接成轻链嵌合抗体V-C,再通过编码柔性肽段(Gly4Ser)的Linker与V连接成单链嵌合抗体ScFV-C,并分别在大肠杆菌的热敏与分泌型表达系统中进行表达。表达产物的Western-blot与间接ELISA检测结果表明,SCFv-C产两种系统中的表达产物均具有抗原结合活性,并已在分泌肽的指导下ScFv-Ck能被E.coli分泌出胞外。  相似文献   

5.
抗结肠癌相关抗原单链抗基因的构建和表达   总被引:3,自引:2,他引:1  
通过PCR扩增和酶切分别得到抗结肠癌相关抗原抗体的重链可变区序列,轻链可变区序列及连接肽序列,将它们构建成为VH-linker-VL形式的单链抗体基因片段,并在大肠杆菌中进行了表达,SDS-PAGE分析结果表明,以pComb3为载体,在大肠杆菌JM83中,scFv未获得有效表达,而以pET-22b(+)为载体的scFv在大肠杆菌BL21(DE3)中,30℃诱导培养获得了高效表达,表达水平占全菌蛋白  相似文献   

6.
将抗癌胚抗原(CEA)单链抗体基因插入家蚕杆状病毒转移载体pBacPAKHis, 与修饰的家蚕核型多角体病毒BmBacPAKDNA共转染家蚕细胞, 经同源重组得到含有在多角体蛋白基因启动子控制下的抗CEAScFv 基因的重组病毒BmBacScFv。用重组病毒分别感染家蚕细胞和幼虫, 在两者中均得到了高效表达, 产物分子量为28kD, 前者占细胞总蛋白的6 % , 后者为0 .3 mg/ 蚕。目的基因在家蚕细胞和幼虫中表达产物经Ni2+IDASepharose6B亲和柱纯化, 前者纯度可达90% 以上, 后者纯度较低; 纯化后的融合蛋白具有CEA 结合活力, 其亲和常数分别为5 .4×108/mol·L- 1 和2.3 ×108/mol·L-1 , 略低于其亲本单抗E7B10 2.7 ×109/mol·L- 1 。  相似文献   

7.
吴炯  费炎灵  温晓燕   《生物工程学报》1997,13(4):394-399
碱性成纤维细胞生长因子(bFGF)参与了许多细胞生长和分化的调控过程。本文采用重组DNA技术在大肠杆菌中高效表达了人bFGF。首先将编码人bFGF基因克隆到pXT表达载体中与其上游的一短S导肽共一阅读框架,bFGF基因的表达受强的T7启动子调控。采用BL21(DE3)大肠杆菌作为宿主菌,用IPTG诱导BL21(DE3)细菌合成的T7RNA聚合酶,后者可催化高水平的bFGF基因表达,其bFGF产量可占总菌体蛋白的42.5%。采用肝素Sepharose一步亲和层析法直接从诱导后的细菌裂解产物中得到纯化的重组人bFGF蛋白。经Western印迹分析证明该蛋白可被人bFGF特异性单克隆抗体所识别。进一步研究证明该蛋白具有刺激NR6R-3T3成纤维细胞增殖的生物学活性,并且这一活性可被人bFGF特异性中和抗体所中和。  相似文献   

8.
应用RT-PCR技术从分泌抗人黑色素瘤单克隆抗体的杂交瘤细胞HB8760中克隆了抗体轻、重链可变区基因,然后用(Gly4Ser)3连接肽基因将VH、VL连接成ScFv基因,并进行了序列测定.计算机分析表明VH,VL均符合小鼠抗体可变区的特征,为功能性重排的抗体可变区基因.VH、VL、linker拼接正确.ScFv基因全长729bp,其中VH基因长360bp,编码120个氨基酸,VL基因长324bp,编码108个氨基酸.在噬菌粒表达载体pCANTAB5E中表达了可溶性的ScFv蛋白,表达产物经流式细胞仪检测可特异地与黑色素瘤细胞结合,不与肝癌、胃癌及良性黑痣细胞结合  相似文献   

9.
将Mn-SOD与抗癌胚抗原(CEA)单链抗体基因(Sc-Fv gene)融合,重组到含T7启动子的表达载体pET-22b(+)中,构建表达质粒pETMn-SOD-ScFv,并转化大肠杆菌BL21(DE3),进行高效表达,表达物占菌体可溶性总蛋白的24%。SDS-PAGE和蛋白质和迹图谱显示表达物分子量为45kD与融合基因编码蛋白质的理论值相符。该蛋白质在大肠杆菌中为泌型表达有利于纯化。RIA测定表  相似文献   

10.
为了获得原抗HFRSV衣壳蛋白McAbF3^1株轻链可变区基因,由连接肽体外连接获得单链抗体基因,在大肠杆菌中表达,从鼠源抗HFRSV衣壳蛋白McAbF3株细胞中分离总RNA,以oligo(dT)18为引物逆转录成cDNA,通过PCR扩增出抗体的轻链(VL)和重链可变区(V11)基因,由连接本外连接获得单链抗体(SeFv)基因。将此单链抗体(SeFv)基因插入原核表达载体PET28a,经大肠杆菌(  相似文献   

11.
为了将可中和对虾白斑综合症病毒(WSSV)的单链抗体P1D3在酵母中实现表达,以原核表达载体M13噬菌粒为模板,设计带有SnaBⅠ和EcoRⅠ酶切位点的特异性引物,通过PCR方法扩增P1D3基因。经过酶切、连接反应将该基因连入大肠杆菌-酵母穿梭质粒pPIC9K上。重组质粒pPIC9K-scFvP1D3经BglⅡ线性化后,用电转化的方法转入毕赤酵母(Pichiapastoris)GS115中。通过PCR和DNA测序,挑选和鉴定阳性克隆。经甲醇诱导,P1D3在酵母中获得分泌表达。ELISA实验结果表明,酵母表达上清液中的单链抗体具有较高的WSSV结合活性,而且其活性要高于大肠杆菌所表达抗体的活性。表达条件优化后,单链抗体在酵母中最高表达量可达302mg/L,为开展对虾被动免疫研究提供了新的抗体来源。  相似文献   

12.
具有谷胱甘肽过氧化物酶活性的含硒单链抗体酶制备   总被引:1,自引:0,他引:1  
 利用RT PCR从分泌有谷胱甘肽结合部位的单克隆抗体杂交瘤细胞株 2F3中 ,扩增出单抗重链可变区和轻链可变区基因 .经DNA测序后 ,用Linker(Gly4 Ser1) 3 构建成单链抗体 (scFv)表达载体pTMF scFv ,将重组质粒pTMF scFv转化到大肠杆菌BL2 1(DE3) ,实现了单链抗体的高效表达 .表达的单链抗体占菌体总蛋白 2 5%~ 30 % .该重组蛋白以包涵体形式存在 ,分子量为 30kD .经过金属螯合亲和层析纯化、复性和凝胶过滤纯化 ,得到电泳均一的单链抗体 .再经化学诱变 ,得到含硒单链抗体酶 ,其谷胱甘肽过氧化物酶活性为 330 0U μmol.采用荧光滴定法测定了单链抗体对谷胱甘肽的结合常数  相似文献   

13.
Antibodies currently constitute the most rapidly growing class of human therapeutics; however, the high-yield production of recombinant antibodies and antibody fragments is a real challenge. High expression of active single-chain antibody fragment (scFv) in Escherichia coli has not been successful, as the protein contains three intramolecular disulfide bonds that are difficult to form correctly in the bacterial intracellular environment. To solve this problem, we fused the scFv gene against VEGF165 with a small ubiquitin-related modifier gene (SUMO) by synthesizing an artificial SUMO–scFv fusion gene that was highly expressed in the BL21(DE3) strain. The optimal expression level of the soluble fusion protein, SUMO–scFv, was up to 28.5% of the total cellular protein. The fusion protein was purified by Ni nitrilotriacetic acid (NTA) affinity chromatography and cleaved by a SUMO-specific protease to obtain the native scFv, which was further purified by Ni-NTA affinity chromatography. The result of the high-performance liquid chromatography showed that the purity of the recombinant cleaved scFv was greater than 98%. The primary structure of the purified scFv was confirmed by N-terminal amino acid sequencing and matrix-assisted laser desorption/ionization time-of-flight mass spectroscopy analysis. In vitro activity assay demonstrated that the recombinant scFv could dose-dependently inhibit VEGF165-induced human umbilical vein-derived endothelial cell proliferation. The expression strategy presented in this study allows convenient high yield and easy purification of recombinant scFv with native sequences.  相似文献   

14.
The murine immunoglobulin G (IgG) cocaine-binding monoclonal antibody (mAb), GNC92H2, is notable for its exquisite specificity for cocaine, as opposed to chemically-related cocaine metabolites, and for its moderately high affinity (K(d) approximately 200 nM) for cocaine. Recently, we described the crystal structure of a mouse/human chimeric Fab construct at 2.3 A resolution. Herein, we report the successful framework humanization of a single-chain Fv (scFv) GNC92H2 construct without loss of affinity for cocaine. In brief, we compared the mAb GNC92H2 sequence to human antibody sequences, and used structure-based design to incorporate mutations (total = 49) that would humanize the framework region without affecting the overall shape of the binding pocket or the key cocaine-contact residues. The codons of the rationally designed sequence were optimized for E. coli expression, and the gene was synthesized by a de novo PCR reaction using 14 overlapping primers. Expression of the scFv construct was significantly improved in E. coli by fusion to thioredoxin. Intriguingly, this construct apparently refolds to form soluble active antibody in the reducing environment of the cytoplasm. Competitive ELISA and equilibrium dialysis demonstrated comparable binding activity between the humanized scFv and the whole IgG. The successful humanization of mAb GNC92H2 should enhance its potential therapeutic value by reducing its overall. immunogenicity.  相似文献   

15.
李燕  李秀岚  严景华 《生物工程学报》2011,27(10):1472-1481
由于新发现的流感病毒抗体CR6261可以中和多种亚型的流感病毒,而且是其VH区结合于流感病毒蛋白HA的保守区,因此该抗体有望成为一种广谱的流感治疗性抗体而备受关注。通过构建真核表达载体pCR6261VH、pCR6261VH-GFP、pCR6261scFv,成功地筛选到在细胞膜上稳定表达CR6261VH、CR6261VH-GFP与CR6261scFv的单克隆细胞系。用流感病毒去感染稳定细胞系,间隔12 h取上清检测病毒血凝效价。结果表明:稳定表达CR6261scFv和CR6261VH-GFP细胞系能够降低病  相似文献   

16.
AIMS: The monoclonal antibody 61BG1.3, recognizing the RgpA protease, has been reported to confer protection against recolonization by the periodontal pathogen Porphyromonas gingivalis in humans. The aim of this study was to express a functional scFv derived from the monoclonal antibody 61BG1.3 on the surface of Lactobacillus paracasei for potential use in the prevention or treatment of periodontal diseases. METHODS AND RESULTS: The scFv was fused to an E-tag and cloned in the Escherischia coli/Lactobacillus shuttle vector pLP501, which mediates surface expression of the scFv. FACS analysis using an anti-E-tag antibody revealed that the scFv was expressed on the surface of the transformed lactobacilli and binding of the scFv to RgpA was shown by ELISA. Lact. paracasei expressing the scFv against RgpA was able to agglutinate P. gingivalis whereas the Lact. paracasei expressing an irrelevant scFv fragment did not. Scanning electron microscopy demonstrated efficient binding of the lactobacilli expressing the scFv anti-RgpA to P. gingivalis. CONCLUSIONS: We have expressed a functional scFv antibody directed against the RgpA protease of P. gingivalis in Lactobacillus. SIGNIFICANCE AND IMPACT OF THE STUDY: These results suggest a potential of Lactobacillus expressing scFvs against P. gingivalis to be used to combat periodontal disease.  相似文献   

17.
Deoxynivalenol (DON), a mycotoxin produced by several Fusarium species, is a worldwide contaminant of food and feedstuffs. The DON-specific single-chain variable fragment (scFv) antibody was produced in recombinant Escherichia coli. The variable regions of the heavy chain (V(H)) and light chain (V(L)) cloned from the hybridoma 3G7 were connected with a flexible linker using an overlap extension polymerase chain reaction. Nucleotide sequence analysis revealed that the anti-DON V(H) was a member of the V(H) III gene family IA subgroup and the V(L) gene belonged to the Vlambda gene family II subgroup. Extensive efforts to express the functional scFv antibody in E. coli have been made by using gene fusion and chaperone coexpression. Coexpression of the molecular chaperones (DnaK-DnaJ-GrpE) allowed soluble expression of the scFv. The scFv antibody fused with hexahistidine residues at the C-terminus was purified by immobilized metal affinity chromatography (IMAC). Soluble scFv antibody produced in this manner was characterized for its antigen-binding characteristics. Its biological affinity as antibody was measured by surface plasmon resonance (SPR) analysis and proved to be significant but weaker than that of the whole anti-DON mAb.  相似文献   

18.
目的:建立一种高效噬菌体文库构建方法,获得抗鸡卵清蛋白(ovalbumin,OVA)的单链抗体(scFv)噬菌体展示文库,筛选鉴定获得OVA单链抗体。方法:用OVA蛋白免疫Balb/C小鼠,选取血清抗体效价高的小鼠提取脾脏RNA,利用RT-PCR方法扩增获得小鼠重链和小鼠轻链基因。通过无缝连接酶一步将小鼠重链基因、轻链基因和linker DNA连接起来,插入噬菌体表达载体中,构建OVA scFv噬菌体展示文库。测定文库容量,对文库进行富集筛选,ELISA鉴定阳性克隆,测序后构建真核表达载体,转入Expi-CHO悬浮细胞进行真核表达,利用Western blot进行鉴定。结果:成功获得库容量为1. 2×10~7cfu的OVA scFv噬菌体展示文库,并从中筛选出8个阳性克隆,选取效价最高的2号克隆,在Expi-CHO悬浮细胞中表达获得可溶性抗体。结论:建立了一种高效构建scFv噬菌体文库的方法,筛选获得高结合活性的OVA单链抗体,并成功进行了真核表达,为OVA ELISA检测试剂盒的研制奠定了基础。  相似文献   

19.
抗人CD3改形单链抗体的构建、表达及活性测定   总被引:5,自引:0,他引:5  
CD3单抗通过多种途径有效地同体的免疫状态,在临床应用中具有极大的潜力。为克服鼠源单抗用于临床的局限性,拟采用抗体工程技术研制抗人CD3改形单链抗体。首先,将鼠源CD3单抗OKT3轻重链CDRs分别移植到人源抗体LS1轻链和Nd重链的框架中,经计算机模拟其空间构象,进行残基替换,确定CD3改形VL、VH氨基酸序列,化学合成改形VL、VH基因,将其分别插入至载体pROH80中,构建成抗人CD3改形单  相似文献   

20.
Antibodies against CD25 would be novel tools for the diagnosis and treatment of adult T cell leukemia lymphoma (ATLL) and many other immune disorders. In our previous work, we successfully produced the single-chain fragment of a variable antibody against CD25, the Dmab(scFv) antibody, using Pichia pastoris. Here, we describe a novel form of an antibody against CD25, the Dmab(scFv)-Fc antibody, also produced by P. pastoris. To construct the Dmab(scFv)-Fc antibody, the Dmab(scFv) antibody was genetically fused to the Fc fragment of a human IgG1 antibody. A fusion gene encoding Dmab(scFv)-Fc antibody was cloned into the pPIC9K plasmid and expressed at high levels, 60–70 mg/l, by P. pastoris under optimized conditions. The Dmab(scFv)-Fc antibody was similar to the Dmab(scFv) antibody in its binding specificity but different in its molecular form and Fc-mediated effector functions. The Dmab(scFv)-Fc antibody and the Dmab(scFv) antibody both bound to CD25-positive MJ cells but not to CD25-negative K562 cells. The Dmab(scFv)-Fc antibody existed as a dimer whereas the Dmab(scFv) antibody was a monomer because it lacks the Fc fragment. The Dmab(scFv)-Fc antibody enhanced the antibody-dependent cellular cytotoxicity of CD25-positive cancer cells, whereas the Dmab(scFv) antibody was inactive in the antibody-dependent cellular cytotoxicity assays. In addition, compared to the Dmab(scFv) antibody, the Dmab(scFv)-Fc antibody showed stronger immunosuppressive activity in the Con A-stimulated lymphocyte proliferation system and in the mixed lymphocyte reaction system. These results demonstrate that the Dmab(scFv)-Fc antibody produced in P. pastoris is functional, and therefore it might be developed as a novel diagnostic and therapeutic tool for ATLL and other immune disorders.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号